Not applicableStudy completedNCT05214573
What this trial is testing
Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk
Who this might be right for
Type 2 DiabetesCardiac Disease
Mayo Clinic 386,301
Showing 20 of 45 results